EFSD/JDRF/NN: EFSD and JDRF and Novo Nordisk: European Programme in Type 1 Diabetes Research

To foster multi-disciplinary research targeted at finding a cure for type 1 diabetes and its complications. The award will normally be in an amount of €100K but the partnership will consider on a case-by-case basis special requests for amounts of up to €400K. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application, so long as the total duration of the award does not exceed three (3) years. The specific goals of the Programme are to:
i. promote the highest quality of basic and clinical biomedical research in Europe and its associated countries applicable to type 1 diabetes;
ii. expedite the practical application of scientific advances in our understanding of the aetiology, pathogenesis, treatment and prevention of type 1 diabetes and its complications;
iii. encourage clinical translational research bridging the bench and the bedside;
iv. increase awareness of type 1 diabetes research throughout Europe.
http://www.europeandiabetesfoundation.org/EFSD-JDRF-Novo/EFSD-JDRF-Novo-RFA12.html